Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Krugerrand 1/10 oz 342.20 1.24 CHF per 1/10 Ounce 12/30/25 11:00 AM Krugerrand 1/2 oz 1,711.00 1.24 CHF per 1/2 Ounce 12/30/25 11:00 AM Popular Articles Copyright ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback